Overview

To Compare and Evaluate the Efficacy and Safety of Ganilever PFS(Prefilled Syringe) and Orgalutran®

Status:
Completed
Trial end date:
2018-03-01
Target enrollment:
Participant gender:
Summary
to compare and evaluate the efficacy and safety of Ganilever PFS and Orgalutran® in infertility women for assisted reproductive technologies
Phase:
Phase 4
Details
Lead Sponsor:
LG Life Sciences
Treatments:
Ganirelix